Lurking within the genomes of nearly all species--including plants, fungi, and even humans--are genes that are passed from generation to generation with no clear benefit to the organism. Called ...
All eyes are on Alnylam as the company awaits entry into the transthyretin amyloid cardiomyopathy market, which currently ...
August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would become the first new drug for treating fibromyalgia in more than 15 years ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback